Breast Cancer Risk Calculator
Estimate your 5-year and lifetime risk of invasive breast cancer using the Gail model. Based on age, family history, reproductive factors, and biopsy history from the NCI BCRAT.
About This Calculator
The Breast Cancer Risk Calculator estimates a woman's risk of developing invasive breast cancer over the next 5 years and over her lifetime using the Gail model (also known as the NCI Breast Cancer Risk Assessment Tool or BCRAT). This widely validated statistical model was developed by Dr. Mitchell Gail and colleagues at the National Cancer Institute and published in the Journal of the National Cancer Institute in 1989. It has since been refined and validated in multiple large-scale populations.
The model considers seven key risk factors: current age (35-90), age at menarche (early menarche increases risk), age at first live birth (later childbirth or nulliparity increases risk), number of first-degree relatives with breast cancer (mother, sisters, daughters), number of prior breast biopsies (more biopsies correlate with higher risk), atypical hyperplasia on biopsy (significantly elevates risk), and race/ethnicity (baseline risk varies by ethnicity). Each factor contributes a relative risk multiplier, and the composite relative risk is applied to an age-specific baseline risk derived from SEER cancer registry data.
The 5-year risk estimate is particularly important for clinical decision-making. A risk of 1.67% or higher is the FDA-established threshold for considering chemoprevention with tamoxifen or raloxifene. The lifetime risk estimate helps women understand their cumulative risk through remaining life expectancy. The Gail model has been validated in over 100,000 women and shows good calibration (E/O ratio 0.90-1.10) for White women, though it may underestimate risk for African American women and overestimate for Hispanic women. It is not designed for women with known BRCA mutations, prior breast cancer, LCIS, or DCIS.
Regional Notes
India: Breast cancer is the most common cancer among women in India, accounting for about 14% of all female cancers. The lifetime risk is approximately 3-4%, significantly lower than Western countries but rising rapidly in urban areas due to lifestyle changes including delayed childbearing, reduced breastfeeding, and increased alcohol consumption. Indian women tend to develop breast cancer at younger ages (median 46-50 vs 62 in the US). The Gail model has not been specifically validated for Indian populations.
United States: The NCI estimates approximately 316,950 new cases of invasive breast cancer in 2025. The lifetime risk for US women is about 12.5% (1 in 8). Screening mammography is recommended every 1-2 years starting at age 40-50 depending on risk factors. The Gail model is the most widely used risk assessment tool in US clinical practice.
United Kingdom: The lifetime risk of breast cancer in UK women is approximately 11.5% (1 in 9). The NHS uses the PREDICT tool for estimating survival benefit and the NICE guidelines recommend the Tyrer-Cuzick model (IBIS) for risk assessment in women with strong family history. The Gail model is less commonly used in UK practice compared to the US.
Frequently Asked Questions
What is the breast cancer risk calculator?
This calculator estimates a woman's 5-year and lifetime risk of developing invasive breast cancer using the Gail model, also known as the NCI Breast Cancer Risk Assessment Tool (BCRAT). It considers age, age at menarche, age at first live birth, number of first-degree relatives with breast cancer, number of prior breast biopsies, presence of atypical hyperplasia on biopsy, and race/ethnicity.
How does the Gail model calculate breast cancer risk?
The Gail model computes a composite relative risk by multiplying the relative risks associated with each individual risk factor. This composite is then applied to an age-specific baseline risk derived from SEER cancer registry data. The result is adjusted for population attributable risk to produce an individualized 5-year risk percentage and lifetime risk estimate.
What factors increase breast cancer risk in the Gail model?
Key risk factors include older age, early menarche (age 11 or younger), late first childbirth (age 30+) or nulliparity, having first-degree relatives (mother, sisters, daughters) with breast cancer, prior breast biopsies (especially with atypical hyperplasia), and White race (which has a higher baseline risk compared to other ethnicities). Each factor independently contributes to the overall risk estimate.
What is considered a high breast cancer risk?
A 5-year risk of 1.67% or higher is generally considered elevated by the NCI, which is the threshold used to determine eligibility for chemoprevention trials and medications. Risk levels are commonly categorized as: Below Average (ratio <0.8x average), Average (0.8-1.2x), Above Average (1.2-2.0x), Moderately High (2.0-4.0x), and High (>4.0x). The average 5-year risk varies by age from about 0.4% at age 35-39 to 2.5% at age 85+.
Can I reduce my breast cancer risk?
Yes, modifiable risk factors include maintaining a healthy weight, regular physical exercise (at least 150 minutes of moderate activity per week), limiting alcohol intake to fewer than one drink per day, avoiding smoking, breastfeeding for at least one year total, and discussing chemoprevention options (tamoxifen, raloxifene, or aromatase inhibitors) with your doctor if you have elevated risk. For women at very high risk, prophylactic mastectomy reduces risk by 90% or more.
What is the accuracy of the Gail model?
The Gail model has been validated in multiple populations. Its accuracy is measured by the ratio of expected to observed cancers (E/O ratio), which ranges from 0.90-1.10 for White women, indicating good calibration. The model tends to slightly overestimate risk for younger women and underestimate for Hispanic and African American women. The concordance statistic (c-statistic) is approximately 0.58-0.64, meaning it performs better than chance but is not highly predictive at the individual level.
Are breast cancer risks different between countries?
Yes, breast cancer incidence varies significantly by country. The United States has a lifetime risk of about 12.5% (1 in 8 women). In the United Kingdom, the lifetime risk is about 11.5% (1 in 9 women). In India, the lifetime risk is lower at about 3-4%, but incidence is rising rapidly in urban areas. These differences reflect variations in reproductive patterns, diet, screening prevalence, and genetic factors. The Gail model was developed and calibrated on US data.
Who should use the breast cancer risk calculator?
The Gail model is designed for women aged 35-90 who have not been diagnosed with breast cancer, lobular carcinoma in situ (LCIS), or ductal carcinoma in situ (DCIS). It is not appropriate for women with a known BRCA1/BRCA2 mutation, who have received chest radiation therapy, or who have a strong family history suggesting hereditary breast cancer syndrome. If you have these conditions, consult a genetic counselor or oncologist for more specialized risk assessment.